Gut microbiome study in kids with autoimmune diseases ends early
NCT ID NCT05176795
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study aimed to compare the gut bacteria of children newly diagnosed with juvenile idiopathic arthritis, type 1 diabetes, or inflammatory bowel disease with those of their healthy siblings. Researchers wanted to see if differences in gut microbes and diet could explain why some children develop these conditions. The study was terminated after enrolling only 4 participants, so no meaningful conclusions could be drawn.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES TYPE1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict how kids with IBD will respond to treatment?
- Can a biologic drug tame juvenile arthritis in kids?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a Weight-Loss drug shield hearts in type 1 diabetes?
- Amniotic cell secretions may fight gut inflammation and scarring โ a lab study puts them to the test